• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小RNA-449a靶向组蛋白去乙酰化酶-1并诱导前列腺癌生长停滞。

miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.

作者信息

Noonan E J, Place R F, Pookot D, Basak S, Whitson J M, Hirata H, Giardina C, Dahiya R

机构信息

Department of Urology, Veterans Affairs Medical Center and University of California, San Francisco, CA 94121, USA.

出版信息

Oncogene. 2009 Apr 9;28(14):1714-24. doi: 10.1038/onc.2009.19. Epub 2009 Mar 2.

DOI:10.1038/onc.2009.19
PMID:19252524
Abstract

Histone deacetylases (HDACs) are frequently overexpressed in broad range of cancer types, where they alter cellular epigenetic programming to promote cell proliferation and survival. However, the mechanism by which HDACs become overexpressed in human cancers remains somewhat of a mystery. In this study, we investigated the expression and functional significance of miR-449a in prostate cancer cells. Using real-time PCR, we found that miR-449a is downregulated in prostate cancer tissues relative to patient-matched control tissue. Introduction of miR-449a into PC-3 prostate cancer cells resulted in cell-cycle arrest, apoptosis and a senescent-like phenotype. In silico analysis of 3'-UTR regions identified a number of genes involved in cell-cycle regulation as putative targets of miR-449a. Using a luciferase 3'-UTR reporter system, we established that HDAC-1 (histone deacetylase 1), a gene that is frequently overexpressed in many types of cancer, is a direct target of miR-449a. Further, our data indicate that miR-449a regulates cell growth and viability in part by repressing the expression of HDAC-1 in prostate cancer cells. Our findings provide new insight into the function of miRNA in regulating HDAC expression in normal versus cancerous tissue.

摘要

组蛋白去乙酰化酶(HDACs)在多种癌症类型中经常过度表达,在这些癌症中,它们会改变细胞的表观遗传程序以促进细胞增殖和存活。然而,HDACs在人类癌症中过度表达的机制仍有些神秘。在本研究中,我们调查了miR-449a在前列腺癌细胞中的表达及其功能意义。通过实时PCR,我们发现相对于患者匹配的对照组织,miR-449a在前列腺癌组织中表达下调。将miR-449a导入PC-3前列腺癌细胞会导致细胞周期停滞、凋亡以及类似衰老的表型。对3'-UTR区域的计算机分析确定了一些参与细胞周期调控的基因作为miR-449a的假定靶标。使用荧光素酶3'-UTR报告系统,我们确定HDAC-1(组蛋白去乙酰化酶1)是miR-449a的直接靶标,HDAC-1在多种癌症类型中经常过度表达。此外,我们的数据表明,miR-449a部分通过抑制前列腺癌细胞中HDAC-1的表达来调节细胞生长和活力。我们的研究结果为miRNA在正常组织与癌组织中调节HDAC表达的功能提供了新的见解。

相似文献

1
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer.微小RNA-449a靶向组蛋白去乙酰化酶-1并诱导前列腺癌生长停滞。
Oncogene. 2009 Apr 9;28(14):1714-24. doi: 10.1038/onc.2009.19. Epub 2009 Mar 2.
2
MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells.微小RNA-21直接靶向MARCKS并促进前列腺癌细胞的抗凋亡和侵袭能力。
Biochem Biophys Res Commun. 2009 Jun 5;383(3):280-5. doi: 10.1016/j.bbrc.2009.03.077. Epub 2009 Mar 18.
3
Screening of histone deacetylases (HDAC) expression in human prostate cancer reveals distinct class I HDAC profiles between epithelial and stromal cells.对人类前列腺癌中组蛋白去乙酰化酶(HDAC)表达的筛查揭示了上皮细胞和基质细胞之间不同的I类HDAC谱。
Eur J Histochem. 2004 Jul-Sep;48(3):273-90.
4
MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation.微小RNA-330作为肿瘤抑制因子,通过E2F1介导的Akt磷酸化抑制作用诱导前列腺癌细胞凋亡。
Oncogene. 2009 Sep 24;28(38):3360-70. doi: 10.1038/onc.2009.192. Epub 2009 Jul 13.
5
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.miR-34a对前列腺癌PC3细胞生长和化疗耐药性的影响。
Biochem Biophys Res Commun. 2008 Dec 5;377(1):114-9. doi: 10.1016/j.bbrc.2008.09.086. Epub 2008 Oct 1.
6
miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon.miR-205通过下调蛋白激酶Cε在人类前列腺中发挥肿瘤抑制功能。
Cancer Res. 2009 Mar 15;69(6):2287-95. doi: 10.1158/0008-5472.CAN-08-2894. Epub 2009 Feb 24.
7
miR-200bc/429 cluster targets PLCgamma1 and differentially regulates proliferation and EGF-driven invasion than miR-200a/141 in breast cancer.miR-200bc/429 簇靶向 PLCγ1,并与 miR-200a/141 相比,差异调节乳腺癌的增殖和 EGF 驱动的侵袭。
Oncogene. 2010 Jul 29;29(30):4297-306. doi: 10.1038/onc.2010.201. Epub 2010 May 31.
8
miR-145 inhibits breast cancer cell growth through RTKN.微小RNA-145通过Rho关联卷曲螺旋蛋白激酶抑制乳腺癌细胞生长。
Int J Oncol. 2009 May;34(5):1461-6.
9
miR-449a causes Rb-dependent cell cycle arrest and senescence in prostate cancer cells.微小RNA-449a可导致前列腺癌细胞发生依赖于视网膜母细胞瘤蛋白的细胞周期停滞和衰老。
Oncotarget. 2010 Sep;1(5):349-58. doi: 10.18632/oncotarget.167.
10
E2F1-inducible microRNA 449a/b suppresses cell proliferation and promotes apoptosis.E2F1 诱导的 microRNA 449a/b 抑制细胞增殖并促进细胞凋亡。
Cell Death Differ. 2010 Mar;17(3):452-8. doi: 10.1038/cdd.2009.188. Epub 2009 Dec 4.

引用本文的文献

1
A Brief Review of MicroRNA Profiling in Human Prostate Cancer Tissues and Plasma.人类前列腺癌组织和血浆中微小RNA谱分析的简要综述
Biomolecules. 2025 Aug 12;15(8):1156. doi: 10.3390/biom15081156.
2
Exploring microRNA targeting as a promising approach for solid tumor treatment.探索将微小RNA靶向作为实体瘤治疗的一种有前景的方法。
Front Oncol. 2025 Jul 21;15:1570093. doi: 10.3389/fonc.2025.1570093. eCollection 2025.
3
Phenolic compounds and epigenetic mechanisms regulating gene expression: effects on human health.酚类化合物与调控基因表达的表观遗传机制:对人类健康的影响
J Physiol Biochem. 2025 Jul 7. doi: 10.1007/s13105-025-01105-7.
4
Exploring the therapeutic potential of natural products in modulating miRNA networks in prostate cancer.探索天然产物在调节前列腺癌miRNA网络中的治疗潜力。
Naunyn Schmiedebergs Arch Pharmacol. 2025 Feb 20. doi: 10.1007/s00210-025-03898-2.
5
Global research landscape and emerging trends of non-coding RNAs in prostate cancer: a bibliometric analysis.前列腺癌中非编码RNA的全球研究格局与新趋势:一项文献计量分析
Front Pharmacol. 2025 Jan 7;15:1483186. doi: 10.3389/fphar.2024.1483186. eCollection 2024.
6
HDAC-driven mechanisms in anticancer resistance: epigenetics and beyond.组蛋白去乙酰化酶驱动的抗癌耐药机制:表观遗传学及其他。
Cancer Drug Resist. 2024 Nov 20;7:46. doi: 10.20517/cdr.2024.103. eCollection 2024.
7
MiRNA-449 family is epigenetically repressed and sensitizes to doxorubicin through ACSL4 downregulation in triple-negative breast cancer.微小RNA-449家族在三阴性乳腺癌中受到表观遗传抑制,并通过下调ACSL4使细胞对阿霉素敏感。
Cell Death Discov. 2024 Aug 22;10(1):372. doi: 10.1038/s41420-024-02128-7.
8
The Role of Non-Coding RNAs in Epigenetic Dysregulation in Glioblastoma Development.非编码 RNA 在胶质母细胞瘤发生中表观遗传失调中的作用。
Int J Mol Sci. 2023 Nov 14;24(22):16320. doi: 10.3390/ijms242216320.
9
MicroRNA-Mediated Regulation of Histone-Modifying Enzymes in Cancer: Mechanisms and Therapeutic Implications.miRNA 介导的癌症中组蛋白修饰酶的调节:机制和治疗意义。
Biomolecules. 2023 Oct 28;13(11):1590. doi: 10.3390/biom13111590.
10
Empowering the Potential of CAR-T Cell Immunotherapies by Epigenetic Reprogramming.通过表观遗传重编程增强嵌合抗原受体T细胞免疫疗法的潜力
Cancers (Basel). 2023 Mar 23;15(7):1935. doi: 10.3390/cancers15071935.